The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients ...

Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday after a 64-year-old woman was diagnosed with the ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. GBS is a rare condition in which a ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

A new study from Cedars-Sinai suggests that some people diagnosed with behavioral-variant frontotemporal dementia (bvFTD) ...

Sri Lanka's cabinet has approved the import of chilled and dried kernel chips equal to 200 million coconuts to fill a ...

While more Sri Lankan corporates are taking sustainability disclosures more seriously, reporting rigorously on environmental impacts is still lacking, the Centre for a Smart Future (CSF) has said.

Instead, recent studies suggest a role for changes in cerebrospinal fluid (CSF) volume. In this article, we will discuss recent mechanistic observations, as well as the consequences of ICP elevation ...

If neurological symptoms develop, seek opinion from a neurologist/physician as early as possible, experts urge ...

Denali Therapeutics DNLI reported primary analysis data from an early to mid-stage study of its pipeline candidate, tividenofusp alfa (DNL310), in 47 patients with Hunter syndrome (MPS II) over a ...